TargetTyrosine-protein phosphatase non-receptor type 2 [V121L](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 24nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [V113L,M114V](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 29nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [G117E](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 32nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [1-298](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 39nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [V113I](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 39nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [M114V](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 45nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2(Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 87nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2(Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 95nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [1-298](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 109nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2 [V121L](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 138nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [L119V](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 142nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [1-298](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 163nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 2(Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 1.60E+3nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 1 [L119V](Homo sapiens (Human))
Merck Frosst Center For Therapeutic Research
Merck Frosst Center For Therapeutic Research
Affinity DataIC50: 1.90E+3nMpH: 6.3 T: 2°CAssay Description:Hydrolysis of substrate FDP was monitored continuously on a Cytofluor microplate reader with excitation and emission wavelengths set at 440 and 515 ...More data for this Ligand-Target Pair
TargetSolute carrier family 22 member 8(Homo sapiens (Human))
Hemoshear Therapeutics
Curated by ChEMBL
Hemoshear Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.51E+6nMAssay Description:Inhibition of human OAT3 assessed as reduction in OAT3-mediated tenofovir transportMore data for this Ligand-Target Pair
TargetSolute carrier family 22 member 6(Homo sapiens (Human))
Hemoshear Therapeutics
Curated by ChEMBL
Hemoshear Therapeutics
Curated by ChEMBL
Affinity DataIC50: 3.86E+6nMAssay Description:Inhibition of human OAT1 assessed as reduction in OAT1-mediated tenofovir transportMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP2C8 in human liver microsomes using amodiaquine as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP2B6 in human liver microsomes using bupropion as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP2D6 in human liver microsomes using bufuralol as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP3A4 in human liver microsomes using midazolam as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP3A5 in human liver microsomes using midazolam as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP3A4 in human liver microsomes using testosterone as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP3A5 in human liver microsomes using testosterone as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP1A2 in human liver microsomes using Phenacetin as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP2B6 in human liver microsomes using bupropion as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP2C8 in human liver microsomes using amodiaquine as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP2D6 in human liver microsomes using bufuralol as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP3A4 in human liver microsomes using midazolam as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP3A5 in human liver microsomes using midazolam as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP3A4 in human liver microsomes using testosterone as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Time-dependent inhibition of CYP3A5 in human liver microsomes using testosterone as substrate preincubated for 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP1A2 in human liver microsomes using Phenacetin as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+7nMAssay Description:Direct inhibition of CYP2C9 in human liver microsomes using diclofenac as substrateMore data for this Ligand-Target Pair